Deadline: 31 July 2024
The AusHealth CureCell Awards are now open to PhD students doing a cell or biological therapy-related project.
Medical research charities AusHealth and CureCell are committed to translating cutting-edge research into real-world, commercial outcomes. The Awards – intended to help with living costs – will be given to students currently enrolled in a PhD, whose research projects have real potential for clinical impact.
CureCell is an Australian not-for-profit investing in outstanding young scientists seeking cures for cancer and autoimmune disease.
Award Information
- Up to five awards of $10,000 are available.
Eligibility Criteria
- AusHealth CureCell Awards are now open to PhD students.
- Applicants should be aware:
- Applications will not be treated as confidential – so don’t submit anything sensitive!
- AusHealth makes no claim to any IP in applications
- All applicants will be deemed to agree to the terms and conditions as stated; AusHealth reserves the right to amend the terms and conditions.
Judging Criteria
- The winner(s) of the 2024 AusHealth CureCell awards will be decided by the CureCell Board of Directors, using the following judging criteria:
- Innovation: The extent to which the therapy is new or original
- Clinical Relevance: The potential applicability of the therapy to real-world clinical settings
- Feasibility: The practicality of the therapy in terms of production, scalability and accessibility to patients
- Communication: Clarity, organization and professionalism in the application and/or pitch (if needed).
For more information, visit CureCell.
